{"gene":"P4HTM","run_date":"2026-06-10T05:19:53","timeline":{"discoveries":[{"year":2002,"finding":"P4H-TM (PH-4) is a novel putative proline 4-hydroxylase that localizes to the endoplasmic reticulum (unlike EGLN1-3 which are cytoplasmic/nuclear), contains an N-terminal EF-hand motif and a C-terminal catalytic domain. Overexpression in cellular reporter assays suppressed HIF transactivation activity dependent on consensus ODDD proline residues, correlated with decreased cellular HIF protein levels.","method":"Cellular reporter assays, overexpression, subcellular localization studies","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — single lab, reporter assay + localization + HIF protein level measurement, but no in vitro enzymatic reconstitution or mutagenesis of catalytic residues","pmids":["12163023"],"is_preprint":false},{"year":2016,"finding":"P4H-TM participates in the oxygen-dependent regulation of HIF; loss of P4h-tm in mice stabilizes HIF-1α in cortical neurons under normoxia and increases expression of certain HIF target genes in hypoxia in tissues with high P4h-tm expression. P4h-tm is most highly expressed in mouse RPE, brain, heart, lung, skeletal muscle, and kidney. P4h-tm-/- mice develop retinal thinning, drusen-like structures, compromised photoreceptor recycling, and renal lipid accumulation/fibrosis with aging.","method":"Knockout mouse model (P4h-tm-/-), western blot for HIF-1α, qRT-PCR for HIF target genes, electroretinography, histology, fractionation/localization studies","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean knockout mouse with multiple orthogonal readouts (HIF stabilization, HIF target gene expression, retinal/renal phenotype), functional consequence clearly tied to P4H-TM's role in HIF regulation","pmids":["27466183"],"is_preprint":false},{"year":2013,"finding":"PHD4 (P4HTM) overexpression in osteosarcoma cells reduced HIF-2α protein levels and stimulated TGF-α expression, which was necessary and sufficient to promote angiogenic sprouting of endothelial cells in vitro and increased tumor blood vessel density in vivo.","method":"Overexpression in osteosarcoma cells, western blot for HIF-2α, in vitro angiogenesis assay, in vivo tumor xenograft","journal":"Molecular cancer research : MCR","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — single lab, multiple orthogonal methods (protein level, in vitro sprouting, in vivo tumor model) but no direct enzymatic assay or reconstitution","pmids":["24048703"],"is_preprint":false},{"year":2019,"finding":"Biallelic loss-of-function variants in P4HTM cause HIDEA syndrome. Three P4H-TM variant proteins (lacking the transmembrane region) expressed in insect cells yielded insoluble protein products, demonstrating loss-of-function at the protein level.","method":"Exome sequencing, Sanger segregation analysis, overexpression in insect cells, SDS-PAGE and western blot to assess protein solubility","journal":"Genetics in medicine : official journal of the American College of Medical Genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — variant protein characterization by expression and solubility assay, multiple families and variants, single lab","pmids":["30940925"],"is_preprint":false},{"year":2019,"finding":"P4h-tm is selectively expressed in mouse brain regions involved in social behavior and anxiety (amygdala, lateral septum, bed nucleus of stria terminalis). P4h-tm-/- mice display reduced fear/anxiety, increased social interaction, and near-complete absence of behavioral despair, a phenotype not seen in mice lacking other Hif-p4h isoforms, establishing a non-redundant CNS role for P4H-TM.","method":"Knockout mouse model, in situ hybridization/immunostaining for brain expression mapping, behavioral assays (open field, Morris swim, forced swim, tail suspension, social interaction)","journal":"Neuropharmacology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — clean KO with defined behavioral phenotype and isoform-specificity controls, but molecular mechanism downstream of P4H-TM in CNS not yet defined","pmids":["31029587"],"is_preprint":false},{"year":2021,"finding":"Biallelic predicted truncating P4HTM variants were associated with significantly decreased mitochondrial respiratory chain complex I activity in muscle, suggesting P4H-TM function is linked to mitochondrial homeostasis. Putative P4H-TM targets noted include HIF, RNA polymerase II, and activating transcription factor 4 (ATF4, implicated in the integrated stress response).","method":"Trio whole-genome sequencing, mitochondrial respiratory chain complex activity assay in muscle biopsy","journal":"European journal of human genetics : EJHG","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single patient, single method for complex I activity; proposed targets are not experimentally confirmed in this paper","pmids":["34285383"],"is_preprint":false},{"year":2022,"finding":"All known pathogenic HIDEA-associated P4HTM variants result in either premature stop codons, intragenic deletion, or amino acid changes that impact the active site or overall stability of the P4H-TM protein, confirming that loss of enzymatic function is the common mechanism.","method":"In silico structural/functional characterization of pathogenic variants, clinical genetics","journal":"Clinical genetics","confidence":"Low","confidence_rationale":"Tier 4 / Moderate — computational (in silico) analysis of variants across multiple patients; no biochemical reconstitution or mutagenesis performed in this paper","pmids":["35908151"],"is_preprint":false},{"year":2024,"finding":"P4h-tm-/- mice exhibit alterations in whole-body energy metabolism including disrupted 24-h oscillations of energy expenditure and locomotor activity, better glucose tolerance and lower fasting insulin under sedation, faster hepatic glycogenolysis, significant muscle weakness, and a reduced ventilatory response to both hypoxia and hypercapnia. The phenotype is attributed to neurological/CNS origins.","method":"Knockout mouse model, indirect calorimetry, glucose and insulin tolerance tests, lactate/FFA measurements, respiratory rate measurements, sedation challenges","journal":"Pflugers Archiv : European journal of physiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — clean KO mouse, multiple physiological readouts, single lab; upstream molecular mechanism not resolved","pmids":["38396259"],"is_preprint":false},{"year":2026,"finding":"p4htm knockout zebrafish exhibit constitutive Hif activation, erythrocytosis, pathological cardiac remodeling, and HIF-dependent hepatic steatosis. Pericardial edema and renal defects in p4htm mutants are mechanistically rescued by Hif-α inhibition, establishing p4htm as a non-redundant regulator of HIF signaling in vivo.","method":"Zebrafish knockout model, genetic epistasis (rescue with Hif-α inhibitor), blood/cardiac/renal/hepatic phenotyping","journal":"Biochemical pharmacology","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean zebrafish KO, epistasis rescue with HIF-α inhibition providing pathway placement, multiple organ systems, recapitulates mammalian findings","pmids":["42114683"],"is_preprint":false},{"year":2023,"finding":"GATA3 binds to the P4HTM locus and ectopic expression of GATA3 in basal breast cancer cells increases P4HTM transcript levels, identifying P4HTM as a downstream transcriptional target of GATA3.","method":"ChIP-seq/genomics data analysis, ectopic GATA3 overexpression with RT-qPCR for P4HTM","journal":"Research square (preprint)","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single lab, preprint, single overexpression experiment; no direct promoter reporter or mutagenesis confirming direct transcriptional regulation","pmids":["36909571"],"is_preprint":true}],"current_model":"P4H-TM is an endoplasmic reticulum-resident transmembrane prolyl 4-hydroxylase that functions as a non-redundant regulator of HIF-α stability: under normoxia it promotes HIF-α degradation (via the prolyl hydroxylation/pVHL pathway), and its loss—whether in mice, zebrafish, or humans with biallelic P4HTM variants—leads to constitutive HIF activation with downstream consequences including erythrocytosis, renal and retinal pathology, metabolic dysregulation, and the severe neurological HIDEA syndrome; its CNS-selective expression pattern underlies a specific role in anxiety, social behavior, and respiratory control that is not shared by the other HIF prolyl hydroxylases."},"narrative":{"mechanistic_narrative":"P4HTM (P4H-TM/PH-4) is an endoplasmic reticulum-resident transmembrane prolyl 4-hydroxylase that acts as a non-redundant regulator of HIF-α stability and thereby of oxygen-dependent gene expression [PMID:12163023, PMID:42114683]. Distinct from the cytoplasmic/nuclear EGLN prolyl hydroxylases, it localizes to the ER through an N-terminal anchor and carries an N-terminal EF-hand motif and a C-terminal catalytic domain; its overexpression suppresses HIF transactivation in an ODDD proline-dependent manner and lowers cellular HIF protein [PMID:12163023]. Loss of P4H-TM stabilizes HIF-1α in normoxic neurons and drives constitutive HIF activation in vivo, with zebrafish epistasis demonstrating that the resulting erythrocytosis, cardiac, renal, and hepatic steatosis phenotypes are HIF-α dependent [PMID:27466183, PMID:42114683]. In mice its highest expression spans RPE, brain, heart, lung, muscle, and kidney, and its loss produces retinal thinning, photoreceptor recycling defects, and renal lipid accumulation/fibrosis with age [PMID:27466183]. A CNS-selective expression pattern in amygdala, lateral septum, and bed nucleus of the stria terminalis underlies a non-redundant role in fear, anxiety, and social behavior not shared by other HIF prolyl hydroxylases, and knockout mice further show disrupted circadian energy metabolism, muscle weakness, and a blunted ventilatory response to hypoxia and hypercapnia of neurological origin [PMID:31029587, PMID:38396259]. Biallelic loss-of-function P4HTM variants, which destabilize or solubilize the protein, cause the severe neurological HIDEA syndrome [PMID:30940925].","teleology":[{"year":2002,"claim":"Established P4H-TM as a distinct, ER-localized prolyl 4-hydroxylase that can suppress HIF activity, raising the question of whether it is a bona fide oxygen-sensing enzyme separate from the EGLN family.","evidence":"Cellular reporter assays, overexpression, and subcellular localization in cultured cells","pmids":["12163023"],"confidence":"Medium","gaps":["No in vitro enzymatic reconstitution or catalytic-residue mutagenesis","Direct hydroxylation of HIF prolines not demonstrated biochemically"]},{"year":2013,"claim":"Showed P4HTM can lower HIF-2α and drive a downstream angiogenic program via TGF-α, linking its HIF-regulatory activity to tissue vascularization.","evidence":"Overexpression in osteosarcoma cells, HIF-2α western blot, in vitro sprouting and in vivo xenograft assays","pmids":["24048703"],"confidence":"Medium","gaps":["Relies on overexpression rather than loss-of-function","No direct enzymatic assay of P4H-TM on HIF-2α"]},{"year":2016,"claim":"Genetic loss-of-function in mice established P4H-TM as a physiological regulator of HIF-1α stability with tissue-specific consequences, moving beyond overexpression artifacts.","evidence":"P4h-tm-/- knockout mouse with HIF-1α western blot, HIF target qRT-PCR, electroretinography, and renal/retinal histology","pmids":["27466183"],"confidence":"High","gaps":["Direct substrate hydroxylation not measured","Mechanism connecting HIF stabilization to retinal/renal pathology not fully resolved"]},{"year":2019,"claim":"Defined a non-redundant CNS role for P4H-TM in anxiety and social behavior absent from other HIF prolyl hydroxylase isoforms, indicating isoform-specific neural function.","evidence":"Knockout mouse behavioral battery with brain expression mapping and isoform-specificity controls","pmids":["31029587"],"confidence":"Medium","gaps":["Downstream molecular mechanism in CNS undefined","Whether behavioral phenotype is HIF-dependent not established"]},{"year":2019,"claim":"Connected P4HTM to human disease, identifying biallelic loss-of-function variants as the cause of HIDEA syndrome and confirming variant proteins are functionally compromised.","evidence":"Exome sequencing with segregation, insect-cell expression and solubility assays of variant proteins","pmids":["30940925"],"confidence":"Medium","gaps":["Solubility loss inferred rather than enzymatic activity measured","Genotype-phenotype mechanism in patients not dissected"]},{"year":2021,"claim":"Raised the possibility that P4H-TM function extends to mitochondrial homeostasis and additional substrates beyond HIF.","evidence":"Trio whole-genome sequencing and muscle complex I activity assay in a single patient","pmids":["34285383"],"confidence":"Low","gaps":["Single patient, single assay","Proposed targets (RNA Pol II, ATF4) not experimentally confirmed","Causal link between P4HTM loss and complex I deficiency not established"]},{"year":2022,"claim":"Consolidated the disease mechanism by showing all known pathogenic variants converge on loss of enzymatic function through truncation, deletion, or active-site/stability disruption.","evidence":"In silico structural/functional analysis of pathogenic variants across patients","pmids":["35908151"],"confidence":"Low","gaps":["Computational only; no biochemical reconstitution or mutagenesis","Predicted active-site impacts not validated functionally"]},{"year":2023,"claim":"Identified upstream transcriptional control of P4HTM, placing it downstream of GATA3 in breast cancer cells.","evidence":"ChIP-seq/genomics analysis and ectopic GATA3 overexpression with RT-qPCR (preprint)","pmids":["36909571"],"confidence":"Low","gaps":["Preprint, single overexpression experiment","No promoter reporter or binding-site mutagenesis confirming direct regulation"]},{"year":2024,"claim":"Expanded the in vivo phenotype to systemic physiology, showing P4H-TM loss disrupts circadian energy metabolism, muscle strength, and respiratory chemosensitivity via CNS-attributed mechanisms.","evidence":"Knockout mouse indirect calorimetry, glucose/insulin tolerance, respiratory and sedation challenges","pmids":["38396259"],"confidence":"Medium","gaps":["Upstream molecular mechanism not resolved","Tissue of origin (CNS vs peripheral) not genetically isolated"]},{"year":2026,"claim":"Provided definitive pathway placement, demonstrating by epistasis that P4H-TM loss-of-function phenotypes are HIF-α-dependent and conserved across vertebrates.","evidence":"Zebrafish knockout with Hif-α inhibitor rescue and multi-organ phenotyping","pmids":["42114683"],"confidence":"High","gaps":["Does not address HIF-independent functions (e.g. mitochondrial/CNS)","Direct hydroxylation chemistry still not reconstituted in vitro"]},{"year":null,"claim":"Whether P4H-TM directly hydroxylates HIF-α prolines (and any non-HIF substrates such as ATF4 or RNA Pol II) via reconstituted enzymatic activity, and how its ER localization and EF-hand motif shape substrate selection, remains unresolved.","evidence":"No in vitro enzymatic reconstitution or substrate hydroxylation assay appears in the corpus","pmids":[],"confidence":"Low","gaps":["No direct biochemical demonstration of prolyl hydroxylation","Non-HIF substrates unconfirmed","Role of EF-hand/calcium sensing in catalysis unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0016491","term_label":"oxidoreductase activity","supporting_discovery_ids":[0,1]},{"term_id":"GO:0016787","term_label":"hydrolase activity","supporting_discovery_ids":[0]}],"localization":[{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[0,1]}],"pathway":[{"term_id":"R-HSA-8953897","term_label":"Cellular responses to stimuli","supporting_discovery_ids":[1,8]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[0,1]}],"complexes":[],"partners":[],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q9NXG6","full_name":"Transmembrane prolyl 4-hydroxylase","aliases":["Hypoxia-inducible factor prolyl hydroxylase 4","HIF-PH4","HIF-prolyl hydroxylase 4","HPH-4"],"length_aa":502,"mass_kda":56.7,"function":"Catalyzes the post-translational formation of 4-hydroxyproline in hypoxia-inducible factor (HIF) alpha proteins. Hydroxylates HIF1A at 'Pro-402' and 'Pro-564'. May function as a cellular oxygen sensor and, under normoxic conditions, may target HIF through the hydroxylation for proteasomal degradation via the von Hippel-Lindau ubiquitination complex","subcellular_location":"Endoplasmic reticulum membrane","url":"https://www.uniprot.org/uniprotkb/Q9NXG6/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/P4HTM","classification":"Not Classified","n_dependent_lines":27,"n_total_lines":1208,"dependency_fraction":0.022350993377483443},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/P4HTM","total_profiled":1310},"omim":[{"mim_id":"618493","title":"HYPOTONIA, HYPOVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA","url":"https://www.omim.org/entry/618493"},{"mim_id":"614584","title":"PROLYL 4-HYDROXYLASE, TRANSMEMBRANE; P4HTM","url":"https://www.omim.org/entry/614584"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Uncertain","locations":[{"location":"Vesicles","reliability":"Uncertain"},{"location":"Cytosol","reliability":"Uncertain"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"choroid plexus","ntpm":161.1}],"url":"https://www.proteinatlas.org/search/P4HTM"},"hgnc":{"alias_symbol":["P4H-TM","PHD4","PH4","HIFPH4","FLJ20262","EGLN4","PH-4"],"prev_symbol":[]},"alphafold":{"accession":"Q9NXG6","domains":[{"cath_id":"2.60.120.620","chopping":"122-173_273-497","consensus_level":"high","plddt":91.1238,"start":122,"end":497},{"cath_id":"1.10.238.10","chopping":"189-271","consensus_level":"high","plddt":88.034,"start":189,"end":271}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9NXG6","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9NXG6-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9NXG6-F1-predicted_aligned_error_v6.png","plddt_mean":81.06},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=P4HTM","jax_strain_url":"https://www.jax.org/strain/search?query=P4HTM"},"sequence":{"accession":"Q9NXG6","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9NXG6.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9NXG6/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9NXG6"}},"corpus_meta":[{"pmid":"16603655","id":"PMC_16603655","title":"PH4 of Petunia is an R2R3 MYB protein that activates vacuolar acidification through interactions with basic-helix-loop-helix transcription factors of the anthocyanin pathway.","date":"2006","source":"The Plant cell","url":"https://pubmed.ncbi.nlm.nih.gov/16603655","citation_count":265,"is_preprint":false},{"pmid":"12163023","id":"PMC_12163023","title":"Overexpression of PH-4, a novel putative proline 4-hydroxylase, modulates activity of hypoxia-inducible transcription factors.","date":"2002","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/12163023","citation_count":132,"is_preprint":false},{"pmid":"23747973","id":"PMC_23747973","title":"Cysteine dioxygenase structures from pH4 to 9: consistent cys-persulfenate formation at intermediate pH and a Cys-bound enzyme at higher pH.","date":"2013","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/23747973","citation_count":61,"is_preprint":false},{"pmid":"16838934","id":"PMC_16838934","title":"Thermodynamic properties of molecular borane phosphines, alane amines, and phosphine alanes and the [BH(4)(-)][PH(4)(+)], [AlH(4)(-)][NH(4)(+)], and [AlH(4)(-)][PH(4)(+)] salts for chemical hydrogen storage systems from ab initio electronic structure theory.","date":"2005","source":"The journal of physical chemistry. A","url":"https://pubmed.ncbi.nlm.nih.gov/16838934","citation_count":51,"is_preprint":false},{"pmid":"26111005","id":"PMC_26111005","title":"Two showy traits, scent emission and pigmentation, are finely coregulated by the MYB transcription factor PH4 in petunia flowers.","date":"2015","source":"The New phytologist","url":"https://pubmed.ncbi.nlm.nih.gov/26111005","citation_count":43,"is_preprint":false},{"pmid":"31728522","id":"PMC_31728522","title":"Citrus PH4-Noemi regulatory complex is involved in proanthocyanidin biosynthesis via a positive feedback loop.","date":"2020","source":"Journal of experimental botany","url":"https://pubmed.ncbi.nlm.nih.gov/31728522","citation_count":32,"is_preprint":false},{"pmid":"30940925","id":"PMC_30940925","title":"Biallelic loss-of-function P4HTM gene variants cause hypotonia, hypoventilation, intellectual disability, dysautonomia, epilepsy, and eye abnormalities (HIDEA syndrome).","date":"2019","source":"Genetics in medicine : official journal of the American College of Medical Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/30940925","citation_count":22,"is_preprint":false},{"pmid":"24048703","id":"PMC_24048703","title":"PHD4 stimulates tumor angiogenesis in osteosarcoma cells via TGF-α.","date":"2013","source":"Molecular cancer research : MCR","url":"https://pubmed.ncbi.nlm.nih.gov/24048703","citation_count":20,"is_preprint":false},{"pmid":"27466183","id":"PMC_27466183","title":"Lack of P4H-TM in mice results in age-related retinal and renal alterations.","date":"2016","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/27466183","citation_count":18,"is_preprint":false},{"pmid":"31029587","id":"PMC_31029587","title":"Null mutation in P4h-tm leads to decreased fear and anxiety and increased social behavior in mice.","date":"2019","source":"Neuropharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/31029587","citation_count":13,"is_preprint":false},{"pmid":"37083980","id":"PMC_37083980","title":"Biallelic Mutations in P4HTM Cause Syndromic Obesity.","date":"2023","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/37083980","citation_count":11,"is_preprint":false},{"pmid":"34285383","id":"PMC_34285383","title":"Biallelic P4HTM variants associated with HIDEA syndrome and mitochondrial respiratory chain complex I deficiency.","date":"2021","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/34285383","citation_count":10,"is_preprint":false},{"pmid":"35908151","id":"PMC_35908151","title":"HIDEA syndrome is caused by biallelic, pathogenic, rare or founder P4HTM variants impacting the active site or the overall stability of the P4H-TM protein.","date":"2022","source":"Clinical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/35908151","citation_count":9,"is_preprint":false},{"pmid":"27089475","id":"PMC_27089475","title":"A chimeric repressor of petunia PH4 R2R3-MYB family transcription factor generates margined flowers in torenia.","date":"2016","source":"Plant signaling & behavior","url":"https://pubmed.ncbi.nlm.nih.gov/27089475","citation_count":8,"is_preprint":false},{"pmid":"38396259","id":"PMC_38396259","title":"Metabolic characteristics of transmembrane prolyl 4-hydroxylase (P4H-TM) deficient mice.","date":"2024","source":"Pflugers Archiv : European journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/38396259","citation_count":5,"is_preprint":false},{"pmid":"34214876","id":"PMC_34214876","title":"Dynamic interactions in the l-lactate oxidase active site facilitate substrate binding at pH4.5.","date":"2021","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/34214876","citation_count":5,"is_preprint":false},{"pmid":"36909571","id":"PMC_36909571","title":"P4HTM: A Novel Downstream Target of GATA3 in Breast Cancer.","date":"2023","source":"Research square","url":"https://pubmed.ncbi.nlm.nih.gov/36909571","citation_count":3,"is_preprint":false},{"pmid":"39582684","id":"PMC_39582684","title":"Clinical characteristics of patients with P4HTM variant-associated epilepsy and therapeutic exploration: a case report and literature review.","date":"2024","source":"Frontiers in neurology","url":"https://pubmed.ncbi.nlm.nih.gov/39582684","citation_count":1,"is_preprint":false},{"pmid":"39612909","id":"PMC_39612909","title":"Novel compound heterozygous P4HTM variants in a girl with developmental and epileptic encephalopathy: First case report of P4HTM variant-associated epileptic encephalopathy.","date":"2024","source":"Seizure","url":"https://pubmed.ncbi.nlm.nih.gov/39612909","citation_count":1,"is_preprint":false},{"pmid":"38441145","id":"PMC_38441145","title":"A pathogenic P4HTM gene variant in two brothers with autism spectrum disorder.","date":"2024","source":"Psychiatric genetics","url":"https://pubmed.ncbi.nlm.nih.gov/38441145","citation_count":1,"is_preprint":false},{"pmid":"38249669","id":"PMC_38249669","title":"Exploring optoelectronic and photocatalytic properties of X2AgBiY6 (X = NH4, PH4, AsH4, SbH4 and Y = Cl, Br): a DFT study.","date":"2024","source":"RSC advances","url":"https://pubmed.ncbi.nlm.nih.gov/38249669","citation_count":1,"is_preprint":false},{"pmid":"40946811","id":"PMC_40946811","title":"Evidence for the major role of PH4⍺EFB in the prolyl 4-hydroxylation of Drosophila collagen IV.","date":"2025","source":"Matrix biology : journal of the International Society for Matrix Biology","url":"https://pubmed.ncbi.nlm.nih.gov/40946811","citation_count":0,"is_preprint":false},{"pmid":"40623901","id":"PMC_40623901","title":"[Clinical study on intravenous human immunoglobulin (pH4) for hypogammaglobulinemia and infection risk following CD20 monoclonal antibody therapy in patients with B-cell non-Hodgkin lymphoma].","date":"2025","source":"Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi","url":"https://pubmed.ncbi.nlm.nih.gov/40623901","citation_count":0,"is_preprint":false},{"pmid":"42114683","id":"PMC_42114683","title":"p4htm acts as a non-redundant regulator of HIF signaling to govern erythropoiesis and renal homeostasis in zebrafish.","date":"2026","source":"Biochemical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/42114683","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.08.05.668786","title":"Evidence for the major role of PH4αEFB in the prolyl 4-hydroxylation of  <i>Drosophila</i>  collagen IV","date":"2025-08-06","source":"bioRxiv","url":"https://doi.org/10.1101/2025.08.05.668786","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.07.16.603687","title":"Chemical inactivation of two non-enveloped viruses follows distinct molecular pathways","date":"2024-07-16","source":"bioRxiv","url":"https://doi.org/10.1101/2024.07.16.603687","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":15074,"output_tokens":2586,"usd":0.042006,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":9941,"output_tokens":3329,"usd":0.066465,"stage2_stop_reason":"end_turn"},"total_usd":0.108471,"stage1_batch_id":"msgbatch_013a8chtv3AWyTqv4z4sEF4C","stage2_batch_id":"msgbatch_01AHsuW63vinsvuTgzmQ3n62","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2002,\n      \"finding\": \"P4H-TM (PH-4) is a novel putative proline 4-hydroxylase that localizes to the endoplasmic reticulum (unlike EGLN1-3 which are cytoplasmic/nuclear), contains an N-terminal EF-hand motif and a C-terminal catalytic domain. Overexpression in cellular reporter assays suppressed HIF transactivation activity dependent on consensus ODDD proline residues, correlated with decreased cellular HIF protein levels.\",\n      \"method\": \"Cellular reporter assays, overexpression, subcellular localization studies\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — single lab, reporter assay + localization + HIF protein level measurement, but no in vitro enzymatic reconstitution or mutagenesis of catalytic residues\",\n      \"pmids\": [\"12163023\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"P4H-TM participates in the oxygen-dependent regulation of HIF; loss of P4h-tm in mice stabilizes HIF-1α in cortical neurons under normoxia and increases expression of certain HIF target genes in hypoxia in tissues with high P4h-tm expression. P4h-tm is most highly expressed in mouse RPE, brain, heart, lung, skeletal muscle, and kidney. P4h-tm-/- mice develop retinal thinning, drusen-like structures, compromised photoreceptor recycling, and renal lipid accumulation/fibrosis with aging.\",\n      \"method\": \"Knockout mouse model (P4h-tm-/-), western blot for HIF-1α, qRT-PCR for HIF target genes, electroretinography, histology, fractionation/localization studies\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean knockout mouse with multiple orthogonal readouts (HIF stabilization, HIF target gene expression, retinal/renal phenotype), functional consequence clearly tied to P4H-TM's role in HIF regulation\",\n      \"pmids\": [\"27466183\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"PHD4 (P4HTM) overexpression in osteosarcoma cells reduced HIF-2α protein levels and stimulated TGF-α expression, which was necessary and sufficient to promote angiogenic sprouting of endothelial cells in vitro and increased tumor blood vessel density in vivo.\",\n      \"method\": \"Overexpression in osteosarcoma cells, western blot for HIF-2α, in vitro angiogenesis assay, in vivo tumor xenograft\",\n      \"journal\": \"Molecular cancer research : MCR\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — single lab, multiple orthogonal methods (protein level, in vitro sprouting, in vivo tumor model) but no direct enzymatic assay or reconstitution\",\n      \"pmids\": [\"24048703\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Biallelic loss-of-function variants in P4HTM cause HIDEA syndrome. Three P4H-TM variant proteins (lacking the transmembrane region) expressed in insect cells yielded insoluble protein products, demonstrating loss-of-function at the protein level.\",\n      \"method\": \"Exome sequencing, Sanger segregation analysis, overexpression in insect cells, SDS-PAGE and western blot to assess protein solubility\",\n      \"journal\": \"Genetics in medicine : official journal of the American College of Medical Genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — variant protein characterization by expression and solubility assay, multiple families and variants, single lab\",\n      \"pmids\": [\"30940925\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"P4h-tm is selectively expressed in mouse brain regions involved in social behavior and anxiety (amygdala, lateral septum, bed nucleus of stria terminalis). P4h-tm-/- mice display reduced fear/anxiety, increased social interaction, and near-complete absence of behavioral despair, a phenotype not seen in mice lacking other Hif-p4h isoforms, establishing a non-redundant CNS role for P4H-TM.\",\n      \"method\": \"Knockout mouse model, in situ hybridization/immunostaining for brain expression mapping, behavioral assays (open field, Morris swim, forced swim, tail suspension, social interaction)\",\n      \"journal\": \"Neuropharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean KO with defined behavioral phenotype and isoform-specificity controls, but molecular mechanism downstream of P4H-TM in CNS not yet defined\",\n      \"pmids\": [\"31029587\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Biallelic predicted truncating P4HTM variants were associated with significantly decreased mitochondrial respiratory chain complex I activity in muscle, suggesting P4H-TM function is linked to mitochondrial homeostasis. Putative P4H-TM targets noted include HIF, RNA polymerase II, and activating transcription factor 4 (ATF4, implicated in the integrated stress response).\",\n      \"method\": \"Trio whole-genome sequencing, mitochondrial respiratory chain complex activity assay in muscle biopsy\",\n      \"journal\": \"European journal of human genetics : EJHG\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single patient, single method for complex I activity; proposed targets are not experimentally confirmed in this paper\",\n      \"pmids\": [\"34285383\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"All known pathogenic HIDEA-associated P4HTM variants result in either premature stop codons, intragenic deletion, or amino acid changes that impact the active site or overall stability of the P4H-TM protein, confirming that loss of enzymatic function is the common mechanism.\",\n      \"method\": \"In silico structural/functional characterization of pathogenic variants, clinical genetics\",\n      \"journal\": \"Clinical genetics\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 4 / Moderate — computational (in silico) analysis of variants across multiple patients; no biochemical reconstitution or mutagenesis performed in this paper\",\n      \"pmids\": [\"35908151\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"P4h-tm-/- mice exhibit alterations in whole-body energy metabolism including disrupted 24-h oscillations of energy expenditure and locomotor activity, better glucose tolerance and lower fasting insulin under sedation, faster hepatic glycogenolysis, significant muscle weakness, and a reduced ventilatory response to both hypoxia and hypercapnia. The phenotype is attributed to neurological/CNS origins.\",\n      \"method\": \"Knockout mouse model, indirect calorimetry, glucose and insulin tolerance tests, lactate/FFA measurements, respiratory rate measurements, sedation challenges\",\n      \"journal\": \"Pflugers Archiv : European journal of physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean KO mouse, multiple physiological readouts, single lab; upstream molecular mechanism not resolved\",\n      \"pmids\": [\"38396259\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"p4htm knockout zebrafish exhibit constitutive Hif activation, erythrocytosis, pathological cardiac remodeling, and HIF-dependent hepatic steatosis. Pericardial edema and renal defects in p4htm mutants are mechanistically rescued by Hif-α inhibition, establishing p4htm as a non-redundant regulator of HIF signaling in vivo.\",\n      \"method\": \"Zebrafish knockout model, genetic epistasis (rescue with Hif-α inhibitor), blood/cardiac/renal/hepatic phenotyping\",\n      \"journal\": \"Biochemical pharmacology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean zebrafish KO, epistasis rescue with HIF-α inhibition providing pathway placement, multiple organ systems, recapitulates mammalian findings\",\n      \"pmids\": [\"42114683\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"GATA3 binds to the P4HTM locus and ectopic expression of GATA3 in basal breast cancer cells increases P4HTM transcript levels, identifying P4HTM as a downstream transcriptional target of GATA3.\",\n      \"method\": \"ChIP-seq/genomics data analysis, ectopic GATA3 overexpression with RT-qPCR for P4HTM\",\n      \"journal\": \"Research square (preprint)\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single lab, preprint, single overexpression experiment; no direct promoter reporter or mutagenesis confirming direct transcriptional regulation\",\n      \"pmids\": [\"36909571\"],\n      \"is_preprint\": true\n    }\n  ],\n  \"current_model\": \"P4H-TM is an endoplasmic reticulum-resident transmembrane prolyl 4-hydroxylase that functions as a non-redundant regulator of HIF-α stability: under normoxia it promotes HIF-α degradation (via the prolyl hydroxylation/pVHL pathway), and its loss—whether in mice, zebrafish, or humans with biallelic P4HTM variants—leads to constitutive HIF activation with downstream consequences including erythrocytosis, renal and retinal pathology, metabolic dysregulation, and the severe neurological HIDEA syndrome; its CNS-selective expression pattern underlies a specific role in anxiety, social behavior, and respiratory control that is not shared by the other HIF prolyl hydroxylases.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"P4HTM (P4H-TM/PH-4) is an endoplasmic reticulum-resident transmembrane prolyl 4-hydroxylase that acts as a non-redundant regulator of HIF-\\u03b1 stability and thereby of oxygen-dependent gene expression [#0, #8]. Distinct from the cytoplasmic/nuclear EGLN prolyl hydroxylases, it localizes to the ER through an N-terminal anchor and carries an N-terminal EF-hand motif and a C-terminal catalytic domain; its overexpression suppresses HIF transactivation in an ODDD proline-dependent manner and lowers cellular HIF protein [#0]. Loss of P4H-TM stabilizes HIF-1\\u03b1 in normoxic neurons and drives constitutive HIF activation in vivo, with zebrafish epistasis demonstrating that the resulting erythrocytosis, cardiac, renal, and hepatic steatosis phenotypes are HIF-\\u03b1 dependent [#1, #8]. In mice its highest expression spans RPE, brain, heart, lung, muscle, and kidney, and its loss produces retinal thinning, photoreceptor recycling defects, and renal lipid accumulation/fibrosis with age [#1]. A CNS-selective expression pattern in amygdala, lateral septum, and bed nucleus of the stria terminalis underlies a non-redundant role in fear, anxiety, and social behavior not shared by other HIF prolyl hydroxylases, and knockout mice further show disrupted circadian energy metabolism, muscle weakness, and a blunted ventilatory response to hypoxia and hypercapnia of neurological origin [#4, #7]. Biallelic loss-of-function P4HTM variants, which destabilize or solubilize the protein, cause the severe neurological HIDEA syndrome [#3].\",\n  \"teleology\": [\n    {\n      \"year\": 2002,\n      \"claim\": \"Established P4H-TM as a distinct, ER-localized prolyl 4-hydroxylase that can suppress HIF activity, raising the question of whether it is a bona fide oxygen-sensing enzyme separate from the EGLN family.\",\n      \"evidence\": \"Cellular reporter assays, overexpression, and subcellular localization in cultured cells\",\n      \"pmids\": [\"12163023\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No in vitro enzymatic reconstitution or catalytic-residue mutagenesis\", \"Direct hydroxylation of HIF prolines not demonstrated biochemically\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Showed P4HTM can lower HIF-2\\u03b1 and drive a downstream angiogenic program via TGF-\\u03b1, linking its HIF-regulatory activity to tissue vascularization.\",\n      \"evidence\": \"Overexpression in osteosarcoma cells, HIF-2\\u03b1 western blot, in vitro sprouting and in vivo xenograft assays\",\n      \"pmids\": [\"24048703\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Relies on overexpression rather than loss-of-function\", \"No direct enzymatic assay of P4H-TM on HIF-2\\u03b1\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Genetic loss-of-function in mice established P4H-TM as a physiological regulator of HIF-1\\u03b1 stability with tissue-specific consequences, moving beyond overexpression artifacts.\",\n      \"evidence\": \"P4h-tm-/- knockout mouse with HIF-1\\u03b1 western blot, HIF target qRT-PCR, electroretinography, and renal/retinal histology\",\n      \"pmids\": [\"27466183\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct substrate hydroxylation not measured\", \"Mechanism connecting HIF stabilization to retinal/renal pathology not fully resolved\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Defined a non-redundant CNS role for P4H-TM in anxiety and social behavior absent from other HIF prolyl hydroxylase isoforms, indicating isoform-specific neural function.\",\n      \"evidence\": \"Knockout mouse behavioral battery with brain expression mapping and isoform-specificity controls\",\n      \"pmids\": [\"31029587\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Downstream molecular mechanism in CNS undefined\", \"Whether behavioral phenotype is HIF-dependent not established\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Connected P4HTM to human disease, identifying biallelic loss-of-function variants as the cause of HIDEA syndrome and confirming variant proteins are functionally compromised.\",\n      \"evidence\": \"Exome sequencing with segregation, insect-cell expression and solubility assays of variant proteins\",\n      \"pmids\": [\"30940925\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Solubility loss inferred rather than enzymatic activity measured\", \"Genotype-phenotype mechanism in patients not dissected\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Raised the possibility that P4H-TM function extends to mitochondrial homeostasis and additional substrates beyond HIF.\",\n      \"evidence\": \"Trio whole-genome sequencing and muscle complex I activity assay in a single patient\",\n      \"pmids\": [\"34285383\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Single patient, single assay\", \"Proposed targets (RNA Pol II, ATF4) not experimentally confirmed\", \"Causal link between P4HTM loss and complex I deficiency not established\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Consolidated the disease mechanism by showing all known pathogenic variants converge on loss of enzymatic function through truncation, deletion, or active-site/stability disruption.\",\n      \"evidence\": \"In silico structural/functional analysis of pathogenic variants across patients\",\n      \"pmids\": [\"35908151\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Computational only; no biochemical reconstitution or mutagenesis\", \"Predicted active-site impacts not validated functionally\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Identified upstream transcriptional control of P4HTM, placing it downstream of GATA3 in breast cancer cells.\",\n      \"evidence\": \"ChIP-seq/genomics analysis and ectopic GATA3 overexpression with RT-qPCR (preprint)\",\n      \"pmids\": [\"36909571\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Preprint, single overexpression experiment\", \"No promoter reporter or binding-site mutagenesis confirming direct regulation\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Expanded the in vivo phenotype to systemic physiology, showing P4H-TM loss disrupts circadian energy metabolism, muscle strength, and respiratory chemosensitivity via CNS-attributed mechanisms.\",\n      \"evidence\": \"Knockout mouse indirect calorimetry, glucose/insulin tolerance, respiratory and sedation challenges\",\n      \"pmids\": [\"38396259\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Upstream molecular mechanism not resolved\", \"Tissue of origin (CNS vs peripheral) not genetically isolated\"]\n    },\n    {\n      \"year\": 2026,\n      \"claim\": \"Provided definitive pathway placement, demonstrating by epistasis that P4H-TM loss-of-function phenotypes are HIF-\\u03b1-dependent and conserved across vertebrates.\",\n      \"evidence\": \"Zebrafish knockout with Hif-\\u03b1 inhibitor rescue and multi-organ phenotyping\",\n      \"pmids\": [\"42114683\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Does not address HIF-independent functions (e.g. mitochondrial/CNS)\", \"Direct hydroxylation chemistry still not reconstituted in vitro\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Whether P4H-TM directly hydroxylates HIF-\\u03b1 prolines (and any non-HIF substrates such as ATF4 or RNA Pol II) via reconstituted enzymatic activity, and how its ER localization and EF-hand motif shape substrate selection, remains unresolved.\",\n      \"evidence\": \"No in vitro enzymatic reconstitution or substrate hydroxylation assay appears in the corpus\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No direct biochemical demonstration of prolyl hydroxylation\", \"Non-HIF substrates unconfirmed\", \"Role of EF-hand/calcium sensing in catalysis unknown\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0016491\", \"supporting_discovery_ids\": [0, 1]},\n      {\"term_id\": \"GO:0016787\", \"supporting_discovery_ids\": [0]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [0, 1]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-8953897\", \"supporting_discovery_ids\": [1, 8]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [0, 1]}\n    ],\n    \"complexes\": [],\n    \"partners\": [],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":6,"faith_total":6,"faith_pct":100.0}}